Tech Company Financing Transactions
Anodyne Nanotech Funding Round
On 5/4/2021, Anodyne Nanotech raised $4.2 million in Seed investment from Big Pi Ventures, Relativity Healthcare Partners and Velocity Equity Partners.
Transaction Overview
Company Name
Announced On
5/4/2021
Transaction Type
Venture Equity
Amount
$4,200,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to continue to develop its Hero Patch platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Wareham St. 3rd Floor
Boston, MA 02118
USA
Boston, MA 02118
USA
Phone
Website
Email Address
Overview
Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company's patent-pending, porous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules (such as monoclonal antibodies) or small molecules (such as ibuprofen) for fast and sustained delivery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jake Lombardo
Chief Technical Officer
Hojat Nejad
VP - Bus. Development
Konstantinos Tzortzakis
Browse more venture capital transactions:
Prev: 5/4/2021: Artio Medical venture capital transaction
Next: 5/4/2021: Bone Health Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs